CLINICAL_TRIALS
trial_result
· 2019-09-16
Clinical Trial Update: A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis [Phase 1]
Summary
A Phase 1b study of MEDI4920 in adults with rheumatoid arthritis has completed, and the results were posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Adult Onset Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2019-09-16